Results 81 to 90 of about 7,066 (126)
Creatine Deficiency Syndromes and the Importance of Creatine Synthesis in the Brain [PDF]
Creatine deficiency syndromes, due to deficiencies in AGAT, GAMT (creatine synthesis pathway) or SLC6A8 (creatine transporter), lead to complete absence or very strong decrease of creatine in CNS as measured by magnetic resonance spectroscopy. Brain is the main organ affected in creatine-deficient patients, who show severe neurodevelopmental delay and ...
Hugues Henry, Olivier Braissant
exaly +7 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Molecular and Cellular Biochemistry, 2003
Since the first description of a creatine deficiency syndrome, the guanidinoacetate methyltransferase (GAMT) deficiency, in 1994, the two further suspected creatine deficiency syndromes--the creatine transporter (CrT1) defect and the arginine:glycine amidinotransferase (AGAT) deficiency were disclosed.
Andreas Schulze
exaly +4 more sources
Since the first description of a creatine deficiency syndrome, the guanidinoacetate methyltransferase (GAMT) deficiency, in 1994, the two further suspected creatine deficiency syndromes--the creatine transporter (CrT1) defect and the arginine:glycine amidinotransferase (AGAT) deficiency were disclosed.
Andreas Schulze
exaly +4 more sources
Defining the Pathogenicity of Creatine Deficiency Syndrome [PDF]
This work examined nine patients with creatine deficiency syndrome (CDS): six with a creatine transport (CRTR) defect and three with a GAMT defect. Eleven nucleotide variations were detected: six in SLC6A8 and five in GAMT. These changes were analyzed at the mRNA level and specific alleles (most of which bore premature stop codons) were selected as ...
Patricia Alcaide +2 more
exaly +5 more sources
Current and Potential New Treatment Strategies for Creatine Deficiency Syndromes
Creatine deficiency syndromes (CDS) are inherited metabolic disorders caused by mutations in GATM, GAMT and SLC6A8 and mainly affect central nervous system (CNS). AGAT- and GAMT-deficient patients lack the functional brain endogenous creatine (Cr) synthesis pathway but express the Cr transporter SLC6A8 at blood-brain barrier (BBB), and can thus be ...
Olivier Braissant
exaly +3 more sources
Methods for the Diagnosis of Creatine Deficiency Syndromes: A Comparative Study
Journal of Neuroscience Methods, 2006The increasing number of patients with creatine deficiency syndromes (CDS) stresses the need to develop screening procedures for the identification these inherited disorders. Guanidinoacetate (GAA) and creatine (Cr) are reliable biochemical markers of CDS and several analytical methods to measure both metabolites have been developed.
Antonia Ribes +2 more
exaly +4 more sources
Creatine and Creatine Deficiency Syndromes: Biochemical and Clinical Aspects
Pediatric Neurology, 2010Creatine deficiency syndromes, which have only recently been described, represent a group of inborn errors of creatine synthesis (L-arginine-glycine amidinotransferase deficiency and guanidinoacetate methyltransferase deficiency) and transport (creatine transporter deficiency). Patients with creatine deficiency syndromes present with mental retardation
Fahmi, Nasrallah +2 more
openaire +2 more sources

